Virginia Mason Providers Lead Global Cancer Health Equity Efforts at SCHD26

Virginia Mason Franciscan Health providers played a pivotal role at the 2026 Summit on Cancer Health Disparities (SCHD26), leading critical discussions on patient navigation, cancer education, and equitable care delivery worldwide.

Key Takeaways

• Dr. David Aboulafia co-chaired SCHD26, guiding program strategy and planning for the global cancer health disparities summit.
• Virginia Mason Franciscan Health played a major leadership role at the 2026 Summit on Cancer Health Disparities (SCHD26) in Bellevue.
• Dr. Joseph Rosales led discussions on patient navigation, highlighting equity in cancer care delivery.
• Clinical experts like Linda Mach contributed to innovation in chemotherapy education and communication.
• Strong Virginia Mason participation reflects a broader institutional commitment to advancing health equity in oncology.

Dr. David Aboulafia Leads SCHD26 as Co-Chair and Health Equity Advocate

Binaytara’s 2026 Summit on Cancer Health Disparities (SCHD26), which took place on March 27-28, drew faculty and attendees from all over the globe. Still, the Bellevue-based conference enjoyed particular leadership support from a hometown hero: Seattle’s Virginia Mason Franciscan Health.

For one, Dr. David Aboulafia, Virginia Mason hematologist-oncologist, stepped into a hands-on leadership position for SCHD26, acting as conference Co-Chair alongside Jefferson Health’s Dr. Ana Maria Lopez. As Co-Chair, Dr. Aboulafia led the SCHD26 Planning Committee as they determined conference faculty, promoted the event, participated in long-term bi-weekly planning meetings, and ultimately guided the Summit’s programmatic direction and tenor. Dr. Aboulafia’s relationship with Binaytara extends even beyond the non-profit’s flagship equity conference, with Dr. Aboulafia having been appointed Chair of the Binaytara Board of Directors in July 2025.

From Session Chairs to Attendees, Virginia Mason Experts Drive Innovation in Patient Navigation and Cancer Education

With the prominent hematologist-oncologist heading up the conference, it’s no surprise that the SCHD26 program was studded with other Virginia Mason names. Dr. Joseph Rosales, fellow Virginia Mason hematologist-oncologist, chaired the session “Innovation in Patient Navigation,” which centered the perspective of patient navigators within the cancer care team. Dr. Rosales received the 2022 Binaytara "Rising Star in Health Equity" award for his leadership in improving cancer care in underprivileged communities—a moniker he’s clearly taking strides to maintain.

Other Virginia Mason faculty include Linda Mach, PharmD, an ambulatory care pharmacist specializing in medication management for hematology and oncology patients. Mach chaired the session “Innovation in Chemotherapy Education and Communication Tools,” leading an impactful panel discussion with fellow pharmacists and nurses.

On the other side of the podium, SCHD26 saw Virginia Mason healthcare provider turnout within the attendees, who helped shape the conference’s larger, health equity-focused conversation through audience questions that helped elevate panel discussions. In her colleague Dr. Aboulafia’s session “Prevention and Early Detection Across Populations,” Mach took to the microphone to ask about vaccine hesitancy: how to balance the necessity of lifesaving vaccines in the midst of the ever-growing skepticism around them.

Whether attendee, session chair, or conference organizer, Virginia Mason’s strong institutional presence at the 2026 Summit on Cancer Health Disparities is a testament to its healthcare providers’ shared commitment to health equity. Couldn’t make SCHD26? Stay tuned for video coverage of the Summit, including Dr. Aboulafia and Dr. Rosales’ sessions.

Frequently Asked Questions About SCHD26 and Cancer Health Equity

What is SCHD26?

SCHD26 (Summit on Cancer Health Disparities 2026) is a global conference focused on improving cancer care access and outcomes for underserved populations, hosted in the Seattle/Bellevue area.

Who is Dr. David Aboulafia?

Dr. David Aboulafia is a Seattle-based cancer specialist at Virginia Mason Franciscan Health who served as Co-Chair of SCHD26 and Chair of the Binaytara Board of Directors.

What role did Virginia Mason play at SCHD26?

Virginia Mason Franciscan Health contributed significantly through conference leadership, session chairing, and active attendee participation focused on cancer health equity.

What topics did Virginia Mason experts cover?

Sessions led by Virginia Mason professionals addressed patient navigation, chemotherapy education, cancer prevention, and vaccine hesitancy in diverse communities.

Why is patient navigation important in cancer care?

Patient navigation helps individuals—especially those in underserved communities—overcome barriers to diagnosis, treatment, and follow-up care, improving outcomes and equity.

How did attendees contribute to SCHD26 discussions?

Healthcare providers, including Virginia Mason staff, actively participated through Q&A sessions, raising critical issues like vaccine hesitancy and access to preventive care.